1 / 22

Space Biomedicine in the UK

Space Biomedicine in the UK. Leicester 10 Nov 2013. Professor David Gradwell Chairman UK Space Biomedicine Consortium Professor of Aerospace Medicine Centre of Human & Aerospace Physiological Sciences King's College London. The Strategic Development of Space Biomedicine in the UK.

lilith
Download Presentation

Space Biomedicine in the UK

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Space Biomedicine in the UK Leicester 10 Nov 2013 Professor David Gradwell Chairman UK Space Biomedicine Consortium Professor of Aerospace Medicine Centre of Human & Aerospace Physiological Sciences King's College London

  2. The Strategic Development of Space Biomedicine in the UK Leicester 10 Nov 2013 Simon N Evetts PhD Coordinator UK Space Biomedicine Consortium Wyle GmbH

  3. Life Science and Biomedicine • Advances in Life Science/Biomed have been a major driver in global economic growth in the last half of the (20th. • For 6 decades the UK has been a world leader (albeit losing ground to the US). • National investment laid the foundation for global impact … • The UK has a strong, internationally renowned Biomedical Heritage • Biomedicine: • 1. The branch of medical science that deals with the ability of humans to tolerate environmental stresses and variations. • 2. The application of the principles of the natural sciences, especially biology and physiology, to clinical medicine

  4. Biomedicine Heritage • Our economy and world standing have a great deal to thank the Biomedicine industry for - itis big business 1 and the UK is good at it! • An active, robust and productive biomedical industry provides us and our society with; • jobs, opportunity, wealth and healthcare benefits. • But science does not stand still… • US, China, India, Singapore, South Korea, Taiwan – all significant investment in their life science/biomed industries. 1the UK’s life science industry is the third largest contributor to the British economy, with more than 4,000 companies contributing £50 billion to GDP (about 5 percent of total UK output!).

  5. Space Biomedicine in the UK – Time to Act! • At present 8% of global pharmaceuticals are being developed in the UK! • … but we must look to the future. • Space will be a significant aspect of future developed societies, we must therefore prepare the ground for space biomedicine. … in fact we have to make up for lost time!

  6. Space Biomedicine in the UK – Time to Act! • There is a new scientific, economic and health related opportunity emerging … Commercial Human spaceflight • This is not a maybe …

  7. ARCASPACE Armadillo Aerospace Astrobotic Technology Beal Aerospace Blue Origin Bigelow Commercial Spaceflight Federation Copenhagen Suborbitals Garvey Spacecraft Heinlein Prize for Advances in Space Commercialization Inspiration Mars Foundation L5 Society MastenSpace Systems Sierra Nevada Orbital Sciences Corporation OTRAG PlanetSpace Reaction Engines RocketplaneKistler RocketShip Tours Rotary Rocket Shackleton Energy Company Space Adventures Space Frontier Foundation SpaceX Starchaser Industries Virgin Galactic X Prize Foundation XCOR Aerospace Commercial human spaceflight companies With significant capabilities and viable business models.

  8. Commercial human spaceflight companies with major hardware developed or under-test • SpaceXDragon - Orbital Capsule • Bigelow - Orbital Capsule • BoeingCST-100 - Orbital Capsule • Excalibur Almaz - Orbital Capsule • PlanetSpaceSilver Dart - Orbital Spaceplane • SpaceDevDream Chaser - Orbital Spaceplane • Reaction EnginesSkylon - Single-Stage-To-Orbit Spaceplane • Scaled CompositesSpaceShipOne - Suborbital Spaceplane • Scaled Composites/Virgin GalacticSpaceShipTwo - Suborbital Spaceplane • XCORLynx - Suborbital Spaceplane • ARCASPACEStabilo and ORIZONT - Suborbital Capsule and Spaceplane • Blue OriginNew Shepard - Suborbital Capsule • PlanetSpaceCanadian Arrow - Suborbital Capsule • Armadillo Aerospace Black Armadillo - Suborbital Capsule • Starchaser Industries Thunderbird and Thunderstar - Suborbital Capsule • Copenhagen Suborbitals HEAT1X and Tycho Brahe - Suborbital Capsule • SpaceXDragon - Orbital Capsule • Orbital Science - Cygnus Orbital Capsule • OTRAG- Orbital Rocket

  9. Space X Virgin Galactic Boeing XCor Blue Origin Bigelow

  10. Space Biomedicine in the UK – Time to Act! • Commercial human spaceflight will transform society!

  11. As an industry in the next few decades commercial human spaceflight has the potential to become as important to the global economy as the airline and tourism industries are today. International tourism combined with passenger transport had been estimated to be worth $575 Billion – together they are the world’s number one export earner! The UK has been remiss in its traditional lack of participation in human spaceflight. The forthcoming space revolution is different to the past in one major respect, the general public, with its plethora of medical conditions, will be the next generation of astronauts. This will place the field of extreme environment medicine squarely in to the mainstream of medical practice. The UK was/is a global authority in the field of Aviation Medicine, so we can also be a global leader in Aerospace Medicine! Space Biomedicine in the UK – Time to Act!

  12. One of the most significant threats to modern society is the coupling of an ageing population with an epidemic of ‘sedentaryism’ in the young! The key challenge posed by long duration exposure to the space environment is fundamentally the same issue … Space Biomedicine in the UK – Time to Act! deconditioning! We can solve space problems whilst simultaneously meeting the needs of our ageing society!

  13. Should we develop Space Biomedicine in the UK? Given the fact that space needs are highly related to certain important terrestrial needs, And that investment in R&D provides significant returns when undertaken appropriately; Given the fact that investing in R&D that serves multiple purposes offers even greater gains; • Given our impressive biomedical heritage, current world standing in biomedical science and aviation medicine capability; • …. the decision to develop space biomedicine as a field of opportunity in the UK, makes total sense. • But to make up for our lost decades of involvement this must be done in a strategic, ‘joined up’ manner, built on solid C3 (Communication, Coordination, Collaboration).

  14. Where are we at the moment? The UK Space Biomedicine Consortium - a collective of over 34 professional organisations (with some non-UK participation) with interests and involvement in academic, research and industrial activities related to the human aspect of human spaceflight. The whole is Why form a consortium? > ∑ parts

  15. Strategic Aims • 1. Enhance UK innovation and growth. • 2. Benefit terrestrial healthcare. • 3. Prepare the UK to effectively participate in future human spaceflight activities. • 4. Contribute to, and benefit from, international collaboration. • (5. Benefit / serve the interests of UKSBC members.)

  16. Strategic Development of space biomedicine in the UK • The policies, objectives and direction of national and international space and medical organisations, have been examined. • So we can see what remains to be done (unexploited niche fields). • We have aligned the Consortium’s knowledge, experience, capabilities and strengths to those fields suited to our member’s skill sets. • Consequently UKSBC has been able to identify R&D themes suitable to underpin a strategy appropriate for the aforementioned aims.

  17. Overarching R&D Themes • Ageing, Lifestyle & Nutrition • Frailty / independent and assisted living. • Pathologies related to inactivity • Intrinsic and extrinsic influences on cell biology. • Influence of nutrition on health status • Influence of exercise on health status • Telemedicine / e-Health / Biotechnology • Ambulatory healthcare • Preventative medicine • Biomonitoring • Spaceflight Health (morbidity in relation to space travel) • Healthcare preparations for commercial human spaceflight. • Human Factors, Performance & Technology. • Optimisation: Improving individual and team performance for personal health and productivity. • Observation: Monitoring and assessing human performance across leisure and operational activities. • Integration: Supporting Human living and performance through Technology; Human Factors, Human Computer Interaction and Human Robot Interaction design and systems integrations. • Resolution: Addressing habitability, environmental and behavioural factors that pose significant risk to health and performance.

  18. What still needs to be accomplished ? • Establish a formal coordination body and appropriate infra-structure to enable continued coordination of space biomedicine across the UK. • Build upon the work of the UKSBC Focus Teams to identify, document and develop the aims and objectives of the specific R&D programmes. • Fully develop, confirm and ratify a UK Space Biomedicine Strategy. • Nationally consolidate the domain with space life sciences (space life & biomedical sciences?). • Establish an education programme that is interrelated with the strategic R&D programmes and associated commercial partners. • Adopt a mechanism to collaborate with industry, coupled with an effective and efficient brain to bench to bedside development and delivery process.

  19. What is being done ? UKSBC went through a review process early in 2013. The result is a reorganisation to better suit the cause. • External review commissioned. • Chairperson post established. • Focus Teams for each theme formed. • A number of organisational adjustments identified –web presence, increased number of industrial members, market analysis required …

  20. What is being done ? Focus Teams • Currently engaging with key organisations within their fields. • Details concerning the policies and objectives of these potential stakeholders / customers are being documented. • Overarching objectives of the theme R&D programmes will be developed in alignment with stakeholder policies and goals. • The development of the 4 theme programmes to provide the foundations for the overall UK Space Biomedicine Strategy. But to what end?

  21. Vision…. • To enable the UK to be able to contribute to, and in certain niche fields, lead international space biomedicine and human spaceflight endeavours. • To be able to harness and apply combined knowhow and resources (greater than individual entities can offer), to provide solutions to societal concerns using the boundary environment that is space. • And do so with the express intension of benefiting terrestrial healthcare! Space back pain

  22. Thank you Questions?

More Related